Short Communication: Emerging Transmitted HIV Type 1 Drug Resistance Mutations Among Patients Prior to Start of First-Line Antiretroviral Therapy in Middle and Low Prevalence Sites in China

Ítems similars

• Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012
  per: Wang, Jing, et al.
  Publicat: (2014)
• Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
  per: Xing, Hui, et al.
  Publicat: (2013)
• The prevalence of transmitted antiretroviral drug resistance in treatment naïve HIV-infected individuals in China
  per: Liao, Lingjie, et al.
  Publicat: (2010)
• Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
  per: Zhao, Shuai, et al.
  Publicat: (2018)
• Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
  per: Zuo, Zhongbao, et al.
  Publicat: (2016)